Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Neurology · Charcot-Marie-Tooth disease

What Is the Life Expectancy for Charcot-Marie-Tooth?

At a Glance

For the vast majority of people, Charcot-Marie-Tooth disease (CMT) does not affect life expectancy. It is a chronic, slowly progressive nerve condition, not a fatal disease. While rare severe forms exist, most individuals with CMT can expect to live a normal lifespan.

For the vast majority of people with Charcot-Marie-Tooth disease (CMT), life expectancy is completely normal [1]. CMT is not a fatal disease. Instead, it is a chronic condition that slowly progresses over decades, primarily affecting the peripheral nerves that control muscle movement and carry sensory information from the arms and legs.

Most individuals with CMT can expect to live as long as someone without the condition. The focus of CMT care is usually on maintaining mobility, managing symptoms (such as foot deformities or nerve pain), and improving quality of life, rather than extending lifespan.

The Most Common Form: CMT1A

The most frequently diagnosed form of the disease is CMT type 1A (CMT1A). If you have been diagnosed with this type, you can be reassured that it is generally not associated with a shortened life expectancy compared to the general population [1][2].

People with CMT1A and other common types typically experience a gradual weakening of the muscles in the feet, lower legs, hands, and forearms. This often leads to physical changes like high arches or hammertoes. While these changes can be challenging and may eventually require assistive devices like braces or walking aids, they do not directly threaten your life. Genetic testing can help confirm your specific CMT subtype and provide more certainty about your prognosis.

Rare Severe and Early-Onset Forms

While standard forms of CMT do not impact lifespan, there are a few very rare exceptions. Some specific, less common types of the disease can cause severe symptoms that may sometimes affect life expectancy:

  • Early-Onset Forms: Conditions such as Dejerine-Sottas syndrome (a severe, early-onset form of CMT) begin in infancy or early childhood and can cause significant health complications early in life [3].
  • Specific Genetic Variants: Certain very rare types of CMT, such as some forms of CMT4 linked to specific gene mutations, can involve multiple body systems and cause severe issues [4][5][6]. Genetic counseling can help you understand your specific risks and family planning options.
  • Breathing Complications: In very rare instances, severe forms of CMT can lead to respiratory insufficiency (difficulty breathing). This can occur due to weakness in the vocal cords or the diaphragm (the main muscle used for breathing) [7][8][9].

Even in more typical cases of CMT, it is possible (though uncommon) to develop breathing issues resulting from respiratory muscle weakness or spinal curvature [9][10][11]. Symptoms to watch for include shortness of breath, particularly when lying flat. Additionally, sleep apnea (breathing repeatedly stopping and starting during sleep) can occur, but it is highly treatable.

Living Well With CMT

Because CMT does not typically alter how long you will live, the goal is to live as well as possible. Working with a neurologist, physical therapist, and occupational therapist can help you manage weakness, address pain, protect your joints, and maintain your independence for as long as possible. Regular check-ups to monitor joint health and breathing function are important parts of proactive, ongoing care.

Common questions in this guide

Is Charcot-Marie-Tooth disease fatal?
For the vast majority of people, Charcot-Marie-Tooth disease is not fatal. Most individuals with CMT, including those with the most common form, CMT1A, have a completely normal life expectancy.
Does CMT1A shorten your lifespan?
No, CMT1A is the most common form of the disease and is not associated with a shortened lifespan. It causes progressive muscle weakness in the lower legs and arms but does not directly threaten your life.
Are there any severe forms of CMT that affect lifespan?
Yes, there are extremely rare early-onset forms, such as Dejerine-Sottas syndrome, that begin in infancy or early childhood. These rare variations can cause significant health complications early in life that may sometimes affect life expectancy.
Can CMT affect your breathing?
In very rare cases, severe forms of CMT can lead to respiratory issues due to weakness in the diaphragm or vocal cords. Symptoms to watch for include shortness of breath, especially when lying flat, or sleep apnea.
What type of doctors treat Charcot-Marie-Tooth disease?
Patients with CMT typically work with a neurologist to monitor nerve and muscle health. Physical therapists and occupational therapists are also essential to help manage weakness, protect joints, and maintain independence.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific genetic mutation or CMT subtype do I have, and how does it typically progress?
  2. 2.Do I need a referral for genetic counseling to better understand my diagnosis and risks for my family?
  3. 3.Should I have my breathing function evaluated or undergo a sleep study to check for sleep apnea?
  4. 4.What routine monitoring schedule do you recommend to track my muscle strength and joint health over the coming decades?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Charcot-Marie-Tooth Disease and Other Hereditary Neuropathies.

    Klein CJ

    Continuum (Minneapolis, Minn.) 2020; (26(5)):1224-1256 doi:10.1212/CON.0000000000000927.

    PMID: 33003000
  2. 2

    Plasma neurofilament light chain as a potential biomarker in Charcot-Marie-Tooth disease.

    Millere E, Rots D, Simrén J, et al.

    European journal of neurology 2021; (28(3)):974-981 doi:10.1111/ene.14689.

    PMID: 33340200
  3. 3

    [A genotyping study of 13 cases of early-onset Charcot-Marie-Tooth disease].

    Xu JL, Zhang Y, Zhao CY, et al.

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2019; (21(7)):670-675.

    PMID: 31315766
  4. 4

    The function of Scox in glial cells is essential for locomotive ability in Drosophila.

    Kowada R, Kodani A, Ida H, et al.

    Scientific reports 2021; (11(1)):21207 doi:10.1038/s41598-021-00663-2.

    PMID: 34707123
  5. 5

    SCO2 mutations cause early-onset axonal Charcot-Marie-Tooth disease associated with cellular copper deficiency.

    Rebelo AP, Saade D, Pereira CV, et al.

    Brain : a journal of neurology 2018; (141(3)):662-672 doi:10.1093/brain/awx369.

    PMID: 29351582
  6. 6

    Reply: The classification of Charcot-Marie-Tooth diseases, a never-ending story: CMT4?

    Shy ME

    Brain : a journal of neurology 2018; (141(9)):e71 doi:10.1093/brain/awy208.

    PMID: 30084871
  7. 7

    Charcot-Marie-Tooth disease: A case report initially manifested by bilateral vocal cord paralysis.

    Mirlohi SH, Tajfirooz S, Rouhi M

    Respiratory medicine case reports 2025; (53()):102154 doi:10.1016/j.rmcr.2024.102154.

    PMID: 39886061
  8. 8

    Noninvasive ventilation and laser-assisted unilateral posterior cordotomy as novel multidisciplinary approaches for Charcot-Marie-Tooth disease 4B vocal cord paralysis: a case report.

    Tabatabaii SA, Kianparsa J, Zavareh MHG, et al.

    Journal of medical case reports 2024; (18(1)):401 doi:10.1186/s13256-024-04742-6.

    PMID: 39217382
  9. 9

    Fontan Failure Secondary to Charcot-Marie-Tooth-Induced Phrenic Neuropathy.

    Abdul TY, Schneider AE, Cetta F, Driscoll DJ

    Texas Heart Institute journal 2018; (45(4)):270-272 doi:10.14503/THIJ-17-6337.

    PMID: 30374244
  10. 10

    A case report of a MODY6 patient coexistence with Charcot-Marie-Toothe 1A syndrome.

    Wang J, Wang C, Chen Y, et al.

    Frontiers in endocrinology 2025; (16()):1502783 doi:10.3389/fendo.2025.1502783.

    PMID: 40026692
  11. 11

    Effectiveness of Sitagliptin and Empagliflozin Combination Therapy in a Patient With Charcot-Marie-Tooth Disease and Comorbid Diabetes Mellitus: A Case Report.

    Wada M, Mizuno Y, Kajiyama A, et al.

    Cureus 2025; (17(8)):e89954 doi:10.7759/cureus.89954.

    PMID: 40951209

This page provides informational content about life expectancy with Charcot-Marie-Tooth disease. It does not replace professional medical advice; always consult your neurologist regarding your specific prognosis and symptom management.

Get notified when new evidence is published on Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.